Insider Trading & Ownership of Christopher Simon

Location
Boston, MA
Summary
The estimated net worth of Christopher Simon is at least $25,552,539 dollars as of 27 May 2026. Christopher Simon is the President & CEO, Director of HAEMONETICS CORP and owns shares of HAEMONETICS CORP (HAE) stock worth about $25.06M. Christopher Simon is the Director of Sotera Health Co and owns shares of Sotera Health Co (SHC) stock worth about $489K.
Signature
Gregory S. Harvey, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher Simon and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • Christopher Simon has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $25,552,539.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: HAEMONETICS CORP ($25,063,517).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher Simon

SHC Forms 3/4/5

Sotera Health Co

Relationship
Director
Holdings value
$489,022
Past year net change
Change %
Report period
22 May 2026

Insider Transactions Reported by Christopher Simon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .